Robotic Surgery — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus

Robotic surgery — most commonly performed using the Intuitive Surgical da Vinci Surgical System (Xi, Si, or Single Port platforms) — is a form of minimally invasive surgery that provides the operating surgeon with three-dimensional high-definition visualisation at up to 10× magnification and EndoWrist articulating instruments with seven degrees of freedom, replicating and exceeding the natural range of motion of the human wrist. Critically, the robotic platform filters physiological hand tremor, translating the surgeon's movements at the remote console into precise, scaled motions inside the patient's body through ports as small as 8 mm.

The da Vinci system has three components: the patient-side cart (with robotic arms holding instruments and camera), the surgeon's console (where the operating surgeon sits and controls all movements), and a vision cart providing image processing. A bedside assistant manages instrument exchanges, suction, and stapling. The robot has no autonomous capability — every movement is controlled by the surgeon in real time.

Robotic surgery has been adopted across surgical specialties including urology, gynaecology, colorectal surgery, thoracic surgery, cardiac surgery, and head and neck surgery. Over 10 million robotic procedures have been performed globally, with more than 1 million annually in the United States alone. It represents one of the most significant advances in surgical technology of the past two decades.

Robotic surgery is applied across a wide range of procedures. In urology, radical prostatectomy for prostate cancer is the most common robotic procedure worldwide, with robotic assistance now standard of care at major cancer centres. Radical cystectomy for bladder cancer and partial nephrectomy for kidney tumours are other common urological applications.

In gynaecology, robotic hysterectomy (for fibroids, cancer, or heavy periods), myomectomy (fibroid removal while preserving the uterus), and sacrocolpopexy (pelvic organ prolapse repair) are performed robotically. Colorectal surgery uses robotic assistance for low anterior resection of rectal cancer, right and left hemicolectomy, and complex adhesiolysis. Thoracic robotic surgery addresses lobectomy for lung cancer, thymectomy, and oesophageal procedures.

Robotic surgery is particularly advantageous in confined anatomical spaces (the pelvis, mediastinum), when fine suturing in deep locations is required, and for surgeons transitioning from open to minimally invasive surgery. Patients who may not be candidates include those with multiple prior abdominal surgeries (extensive adhesions), haemodynamic instability, or morbid obesity with extreme body habitus in some configurations.

Preoperative preparation includes anaesthetic assessment, bowel preparation for colorectal cases, and antibiotic prophylaxis. The patient is positioned on the operating table in the Trendelenburg (head-down) or other procedure-specific position and secured to prevent intraoperative movement.

Carbon dioxide pneumoperitoneum (12–15 mmHg) is established via a Veress needle or Hasson technique. Three to four 8–12 mm trocars are placed at planned port sites; a 12 mm camera port is positioned at the umbilicus or supra-umbilically. The robotic cart is rolled in and docked to each port; this docking process takes 5–15 minutes and varies by platform and procedure.

The surgeon moves to the remote console, inserts a 3D high-definition camera, and the robotic arms follow all hand and foot pedal commands. Instruments (monopolar scissors, bipolar forceps, needle drivers, stapling instruments) are exchanged by the bedside assistant. Tissue dissection, vessel ligation with energy devices (Ligasure, Harmonic), lymph node dissection, anastomosis, and suturing are performed robotically. At completion, the specimen is extracted through an extended port site or separately placed extraction site, all trocar sites are closed, and the patient is transferred to recovery. Total operative time ranges from 90 minutes for simple hysterectomy to 4–5 hours for complex rectal resection or radical prostatectomy.

Robotic prostatectomy consistently demonstrates positive surgical margin rates of 8–15% for organ-confined disease, with superior potency and continence outcomes compared to open radical prostatectomy due to improved nerve-sparing visibility. Blood loss is significantly reduced across procedures — mean blood loss in robotic prostatectomy is 150–200 mL versus 750–1500 mL for open.

Hospital stay is typically 1–3 days compared to 4–7 days for equivalent open procedures, reducing hospital-acquired infection risk and cost. Patients experience less post-operative pain, requiring fewer opioid analgesics, and return to normal activities and work 2–4 weeks earlier than after open surgery.

For robotic colorectal surgery (ROLARR trial and subsequent data), conversion to open surgery occurs in only 8.1% versus 12.2% for conventional laparoscopy, with faster learning curve mastery. Outcomes for robotic hysterectomy show equivalent oncological results to open surgery with dramatically reduced morbidity. Patient satisfaction scores are consistently high, with improved body image due to smaller incision scars.

Robotic surgery shares all risks of conventional laparoscopic and open surgery, with some procedure-specific additional considerations. Conversion to open or laparoscopic surgery occurs in 1–3% of cases, most commonly due to inadequate visualisation, bleeding, or anatomical complexity beyond robotic capability.

Port-site complications (haematoma, hernia) occur in approximately 1–2% of cases. Carbon dioxide-related complications include subcutaneous emphysema, pneumothorax, and rare CO2 embolism (less than 0.1%). Prolonged operative time from robotic setup and docking (especially during the learning curve) increases anaesthetic exposure. Instrument malfunction, though uncommon with modern systems, can require conversion.

Procedure-specific risks remain: urinary incontinence (3–10%) and erectile dysfunction (20–50%) after robotic prostatectomy; anastomotic leak (3–5%) after robotic colectomy; ureteric injury during robotic hysterectomy (0.3%). Positioning injuries (brachial plexus strain in steep Trendelenburg) are reported. The high equipment cost means robotic surgery may not be universally available, and surgeon experience significantly affects outcomes.

The recovery advantage of robotic over open surgery is one of its most compelling benefits. Patients typically ambulate (walk) on the same day or first post-operative day, reducing deep vein thrombosis risk. Hospital discharge occurs at 1–3 days for most robotic procedures versus 4–7 days for equivalent open surgery.

Post-operative pain is significantly reduced due to smaller port incisions (versus a 15–30 cm laparotomy incision), resulting in lower opioid consumption and associated side effects. Port site wounds (8–12 mm) heal within 5–7 days and require minimal dressing care.

Return to light activities (driving, desk work) occurs within 1–2 weeks for most patients. Heavy lifting and strenuous exercise are avoided for 4–6 weeks. Procedure-specific recovery considerations apply: catheter removal after prostatectomy at 7–14 days, dietary progression after colorectal resection over 3–5 days, and hormonal considerations after hysterectomy. Follow-up appointments at 2 weeks and 6 weeks confirm wound healing, review histopathology, and address any functional recovery issues such as urinary or sexual function rehabilitation.